TY - JOUR
T1 - Upregulation of adenosine A2A receptor in astrocytes is sufficient to trigger hippocampal multicellular dysfunctions and memory deficits
AU - Launay, Agathe
AU - Carvalho, Kevin
AU - Genin, Athénais
AU - Gauvrit, Thibaut
AU - Nobili, Paola
AU - Gomez-Murcia, Victoria
AU - Augustin, Emma
AU - Burgard, Anaëlle
AU - Gambi, Johanne
AU - Fourmy, Déborah
AU - Thiroux, Bryan
AU - Vieau, Didier
AU - Bemelmans, Alexis Pierre
AU - Le Gras, Stephanie
AU - Buée, Luc
AU - Orr, Miranda E.
AU - Audinat, Etienne
AU - Boutillier, Anne Laurence
AU - Bonvento, Gilles
AU - Cambon, Karine
AU - Faivre, Emilie
AU - Blum, David
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025/11
Y1 - 2025/11
N2 - Adenosine is an ubiquitous neuromodulator that ensures cerebral homeostasis. It exerts numerous functions through the activation of G-protein-coupled adenosine receptors (ARs), in particular A1 (A1R) and A2A (A2AR) receptors. Interestingly, A2AR levels are upregulated in cortical and hippocampal regions in several pathological conditions such as Alzheimer’s disease, tauopathies or epilepsia. Such abnormal upregulations have been particularly reported in astrocytes, glial cells that play a key role in regulating synaptic plasticity. However, the overall impact and the underlying mechanisms associated with increased A2AR in astrocytes remain poorly understood. In the present study, we induced the upregulation of A2AR in hippocampal astrocytes using dedicated AAVs and comprehensively evaluated the functional consequences in 4 months-old C57Bl6/J mice. Our results show that A2AR upregulation primarily promotes alterations of astrocyte reactivity, morphology and transcriptome, with a link to aging-like phenotype as well as secondary impairments of neuronal excitability and microglial phenotype. These changes driven by a restricted A2AR upregulation in hippocampal astrocytes were sufficient to induce impairments of short-term spatial memory and spatial learning. This study highlights the impact of astrocytic A2AR upregulation, as seen in various neurological conditions, on the development of a detrimental multicellular response associated with memory alterations and provides an additional proof-of-concept for the value of targeting this receptor in different neurodegenerative conditions.
AB - Adenosine is an ubiquitous neuromodulator that ensures cerebral homeostasis. It exerts numerous functions through the activation of G-protein-coupled adenosine receptors (ARs), in particular A1 (A1R) and A2A (A2AR) receptors. Interestingly, A2AR levels are upregulated in cortical and hippocampal regions in several pathological conditions such as Alzheimer’s disease, tauopathies or epilepsia. Such abnormal upregulations have been particularly reported in astrocytes, glial cells that play a key role in regulating synaptic plasticity. However, the overall impact and the underlying mechanisms associated with increased A2AR in astrocytes remain poorly understood. In the present study, we induced the upregulation of A2AR in hippocampal astrocytes using dedicated AAVs and comprehensively evaluated the functional consequences in 4 months-old C57Bl6/J mice. Our results show that A2AR upregulation primarily promotes alterations of astrocyte reactivity, morphology and transcriptome, with a link to aging-like phenotype as well as secondary impairments of neuronal excitability and microglial phenotype. These changes driven by a restricted A2AR upregulation in hippocampal astrocytes were sufficient to induce impairments of short-term spatial memory and spatial learning. This study highlights the impact of astrocytic A2AR upregulation, as seen in various neurological conditions, on the development of a detrimental multicellular response associated with memory alterations and provides an additional proof-of-concept for the value of targeting this receptor in different neurodegenerative conditions.
UR - https://www.scopus.com/pages/publications/105011641338
U2 - 10.1038/s41380-025-03115-9
DO - 10.1038/s41380-025-03115-9
M3 - Article
C2 - 40702259
AN - SCOPUS:105011641338
SN - 1359-4184
VL - 30
SP - 5300
EP - 5314
JO - Molecular Psychiatry
JF - Molecular Psychiatry
IS - 11
ER -